Curriculum Vitae Personal details Born in Esztergom (Hungary), on the 30 th of November,

Transcription

1 Gergő Merész H-1118 Budapest, Hungary Povl Bang-Jensen street 2/B Curriculum Vitae Personal details Born in Esztergom (Hungary), on the 30 th of November, Education : Eötvös Loránd University, Budapest (Hungary), Faculty of Social Sciences, Health policy planning and financing (MA), specialization in Health Economics : University of Szeged (Hungary), Faculty of Arts, Sociology (BA) : Szent István Secondary Grammar School, Esztergom (Hungary) Other relevant education August 2012: Erasmus Summer Programme, Erasmus University Rotterdam (Netherlands) Causal Inference; Introduction to Global Public Health; Advances in Epidemiologic Analysis; Methods of Public Health Research; Methods of Health Services Research; Logistic Regression; The Why and How of Readable Articles Distance learning: Health Policy and the Affordable Care Act, University of Pennsylvania (July / August 2012); Computing for Data Analysis, Johns Hopkins University (September / October 2012); Data Analysis, Johns Hopkins University (January / February 2013); Rationing and Allocating Scarce Medical Resources, University of Pennsylvania (May / July 2013), Reproducible Research, Johns Hopkins University (May / June 2014) Work experience August 2015: Semmelweis University, Health Services Training Centre, Expert July 2011 August 2015: Syreon Research Institute, Economic Modeling Division, Health economist September 2010-June 2011: Syreon Research Institute, Intern/trainee (involved in a project before internship as well) May February 2011: Healthware Consulting Ltd., Intern/trainee (biostatistics division) October May 2010: Eötvös Loránd University, Faculty of Social Sciences, Institute of Health Policy and Health Economics, trainee

2 Tutoring experience and public activity Eötvös Loránd University, Budapest (Hungary), Faculty of Social Sciences, part-time lecturer (2011-present) Arab Academy for Science, Technology and Maritime Transport, Health Economics Diploma programme, assistant lecturer (14-31 st of March 2013) Eötvös Loránd University, Implementation of HTA in Central-Eastern European countries, assistant lecturer (25-28 th of June 2013.) Decision making based on economic modelling in reimbursement submission files, assistant lecturer (22-24 th of July and 3-5 th of September 2013) Oppenent of numerous master thesises, complete thesis supervision of one student (Eszter Takács: The impact of international price referencing on pharmaceutical expenditure after the millenium, based on the aggregated data of 21 European countries), one other thesis supervision in progress. Eötvös Loránd University, Budapest (Hungary), Faculty of Social Sciences, member of student faculty committee (2010/2011) Member of the Hungarian Health Economics Association (2010-) Other relevant knowledge Advanced level language certificate in English; intermediate level language certificate in French Solid knowledge of R, user-level knowledge of Stata, SPSS statistical softwares Knowledge of MS Office applications (Word, Excel, PowerPoint, Access), with knowledge of Visual Basic Awards Best master thesis in class, 2011: The safety and efficacy of insulin detemir: meta-analysis (ELTE University) Best Hungarian publication, 2011: Assessment of the pharmaceutical expenditure in Hungary (Hungarian Health Economics Association) Best Hungarian publication, 2013: Health economic model to assess the screening, treatment and management strategies of diabetes (Hungarian Health Economics Association) 2

3 List of publications Journal articles A Inotai, G Merész, Z Kaló: Assessment of the pharmaceutical expenditure in Hungary [Hungarian]. Acta Pharmaceutica Hungarica, 2010;80(4): A Inotai, G Merész, Z Kaló: Evaluating the pharmaceutical expenditure in Hungary on behalf of the Széll Kálmán programme [Hungarian]. Egészségügyi Gazdasági Szemle, Gyógyszerpiaci különszám, p /6. Z Kaló, G Merész, D Mezei, Á Tótth, A Inotai: The foundation and consequences of measures regarding the pharmaceutical sector in the Széll Kálmán programme. [Hungarian]. IME, 2012;9(6): B Nagy, L Nagyjánosi, Sz Nagyistok, J Józwiak-Hagymássy, G Merész, E Papp, Z Dessewffy, Gy Jermendy, G Winkler, Z Kaló, Z Vokó: Health economic model to assess the screening, treatment and management strategies of diabetes [Hungarian]. Diabetologia Hungarica, 2012;20(4): B Nagy, G Merész. Role of risk-sharing in health care [Hungarian]. Egészségügyi Gazdasági Szemle, 2012;50(4): G Merész, Z Kaló, Á Tabák: Cost minimisation analysis of basal insulin analogues for treatment of type 2 diabetes [Hungarian]. Lege Artis Medicinae, 2012;22(12): É Orosz, G Merész, B Nagy: Investment to human capital: fallback from the developed countries? [Hungarian] Educatio, 2013, 12(2): G Merész, B Németh, B Sinkovits: VII. IME-META Advanced Training and Conference on Health Economics: Is the crisis an opportunity or a curse? Conference Report. Acta Oeconomica Volume 63, Number 3, September 2013., p B Nagy, G Timár, J Józwiak-Hagymásy, G Kovács, G Merész, I Vámossy, T Agh, A László, Z Vokó, Z Kaló. The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids. Eur J Obstet Gynecol Reprod Biol Jan 31. pii: S (14) doi: /j.ejogrb G Merész, Cs Földesi, Sz Nagyistók, ÁZ Vincziczki. Changes on the market of publications and a dynamising health economic community [Hungarian] Egészségügyi Gazdasági Szemle 2014/2-3, p Reports Z Kaló, G Merész, D Mezei, Á Tótth, A Inotai: Assessment of the pharmaceutical expenditure in Hungary - the foundation and consequences of measures regarding the pharmaceutical sector in the Széll Kálmán programme [Hungarian]. Available at Conference presentations and posters G Merész, A Inotai, Z Kaló: Assessment of the pharmaceutical expenditure in Hungary. IME-META V. National Health Economic Training and Conference, presentation, Budapest, 29 th and 30 th of June, A Inotai, G Merész, J Józwiak-Hagymási, Z Kaló: Burden of disease model of disease-related malnutrition in Europe [Hungarian]. IME-META V. National Health Economic Training and Conference, presentation, Budapest, 29 th and 30 th of June, A Inotai, G Merész, Z Kaló: Government Reduces Public Pharmaceutical Expenditure in Hungary: Rational Decisions in Challenging Economic times?, ISPOR 14 th Annual Europenan Congress. Poster, Madrid, 5 th to 8 th of November Abstract in: Value in Health, Volume 14, Issue 7, November 2011, Page A346 B Nagy, L Nagyjánosi, Sz Nagyistók, J Józwiak-Hagymásy, Z Dessewffy, G Merész, Z Kaló, Z Vokó: Development of a health economic model to compare the prevention, treatment and management strategies of type 2 diabetes. ISPOR 14 th Annual Europenan Congress. Poster, Madrid, 5 th to 8 th of November Abstract in: Value in Health, Volume 14, Issue 7, November 2011, Page A486 3

4 Z Kaló, A Inotai, G Merész: International comparison of pharmaceutical expenditure in middle income countries: methodological questions. ISPOR 17 th Annual International Meeting. Poster, Washington, 2 nd to 6 th of June 2012., Abstract in: Value in Health, Volume 15, Issue 4, June 2012, Page A21 J Józwiak-Hagymási, G Merész,. I Marton, L Nagyjánosi, Sz Nagyistók, Z Dessewffy, B Nagy, Z Vokó, Z Kaló: Estimating costs and outcomes in the health economic model to compare the prevention, treatment and management strategies of type 2 diabetes [Hungarian]. IME-META VI. National Health Economic Training and Conference, presentation, Budapest, 20 th and 21 st of June, G Merész, L Nagyjánosi, Z Dessewffy, Z Vokó, Z Kaló: Internal validation of the health economic model to compare the prevention, treatment and management strategies of type 2 diabetes [Hungarian]. IME-META VI. National Health Economic Training and Conference, presentation, Budapest, 20 th and 21 st of June, B Nagy, J Józwiak-Hagymásy, Gy Tímár, G Kovács, G Merész, I Vámossy, T Ágh, Z Vokó, Z Kaló: Economic evaluation of Esmya tablets for the preoperative treatment of patients with moderate and severe symptoms uterine fibroids. [Hungarian]. IME-META VI. National Health Economic Training and Conference, presentation, Budapest, 20 th and 21 st of June, G Merész, L Nagyjánosi, B Nagy, Z Dessewffy, Z Vokó, Z Kaló: Internal validation of the Syreon diabetes model. ISPOR 15 th Annual Europenan Congress. Poster, Berlin, Germany, November, Abstract in: Value in Health, Volume 15, Issue 7, November 2012, Page A475. B Nagy, Gy Tímár, J Józwiak-Hagymásy,G Kovács, G Merész, I Vámossy, T Ágh, Á László, Z Vokó, Z Kaló: Economic evaluation of ulipristal acetate tablets for the treatment of patients with moderate and severe symptoms uterine fibroids. ISPOR 15 th Annual Europenan Congress. Poster, Berlin, Germany, November, Abstract in: Value in Health, Volume 15, Issue 7, November 2012, Page A540. C Boehler, G Merész, Z Kaló: Pharmaceutical spending levels across Europe Consequences of current international pricing policies on lower income countries. ISPOR 18 th Annual International Meeting. Poster, New Orleans, United States of America, May Abstract in: Value in Health Vol. 16, Issue 3, Page A255. A Zsólyom, G Merész, L Nagyjánosi, Sz Nagyistók, Z Dessewffy, B Nagy, Z Kaló, Z Vokó: External validation of the health economic model to compare the prevention, treatment and management strategies of type 2 diabetes IME-META VII. National Health Economic Training and Conference, presentation, Budapest, 19 th and 20 th of June, G Merész, L Kóbori, D Mocsari, É Kosóczki, G Hirka, K Monostory, Z Kaló: Personalized medicine in kidney transplantation: economic evaluation of the CYPtest TM diagnostic procedure. [Hungarian] IME-META VII. National Health Economic Training and Conference, presentation, Budapest, June, A Zsólyom, G Merész, L Nagyjánosi, Sz Nagyistók, B Nagy, Z Kaló, Z Vokó: External validation of the Syreon Diabetes Model. ISPOR 16th Annual European Congress, Poster, Dublin, Ireland, November, Abstract in: Value in Health Vol. 16, Issue 7, Page A590. G Merész, Cs Földesi, Sz Nagyistók, ÁZ Vincziczki. Publication activity among the members of the Hungarian Health Economics Association [Hungarian]. IME-META VIII. National Health Economic Training and Conference, presentation and poster, Budapest, 18 th and 19 th of June, E Takács, G Merész, P Elek, Z Kaló. Effect of international reference pricing on pharmaceutical expenditure trends [Hungarian]. IME-META VIII. National Health Economic Training and Conference, poster, Budapest, 18 th and 19 th of June, G Merész: Depicting the spatial arrangement of clinical trial sites [Hungarian]. Presentation. Budapest Users of R Network Meetup, Budapest, 16 th of July G Merész: Analysing scientometric data to relevate publication activity and coauthor networks [Hungarian]. Presentation. Natural Language Proccession Meetup, Budapest, 25 th of September G Merész, G Gyurcsán, B Salfer: Easy come, hardly go: epidemiological methods to evaluate the effect of ISPOR Board of Directors memebership on publication activity. ISPOR 17 th Annual European Congress, Poster, Amsterdam, The Netherlands, November, G Merész: Coauthor networks: beyond citations. Presentation. Budapest Business Intelligence Forum 2014, Open Analytics Day, Budapest, th November

5 G Merész, K Csetneki, A Inotai A, Z Kaló. International Comparison Of Pharmaceutical Expenditures In Central-Eastern European Countries: Methodological Questions. IX. Hungarian Health Economic Training and Conference, oral presentation, Budapest, th June,